BOZEMAN, Mont — Golden Helix, Inc. announced that it has received the certification for ISO 13485:2016 from TÜV SÜD. ISO 13485:2016 is an international standard that specifies requirements for a quality management system (QMS) for organizations involved in the design, development, production, and servicing of medical devices. It is specifically tailored to the medical device industry […]
Completion of this comprehensive certification process underscores the quality of the processes used to support the company’s GMP product portfolio MADISON, Wis. — Mirus Bio, a life sciences company developing innovative solutions for nucleic acid delivery to support cell and gene therapy production, biopharmaceutical manufacturing, and research applications, today announced that its quality management system […]
Hadfield, UK – UK genomics company, RevoluGen Ltd. has demonstrated a new protocol for automated bead-based high molecular weight HMW-DNA extraction with its proprietary Fire Monkey chemistry. Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid handling robot to produce ready to […]
New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer panel at 3377x coverage in just 6 minutes for less than $0.72 per test Included in market-leading CLC Genomics analysis platform for desktop, server or cloud use Enhances QDI’s leading portfolio of NGS analysis and […]
BioSkryb to introduce new products and novel applications of industry-leading portfolio that advance the single-cell multiomics field through simultaneous interrogation of DNA, RNA, and targeted proteins from each cell DURHAM, N.C. – BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete DNA-informed multiomic view of the cellular ecosystem, today announced that it […]
FREMONT, Calif. — Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput sequencing architecture, today announced the launch and full commercial availability of the UG 100™ at the upcoming Advances in Genome Biology and Technology (AGBT) conference on February 5, 2024. The UG 100™ system, Ultima’s first commercial product, leverages a unique sequencing […]
COLOGNE, Germany — Singleron Biotechnologies, a leader in single cell multi-omic solutions for precision medicine, announced two new commercial product launches : AccuraSCOPE® Single Cell Transcriptome and Genome Library Kit and the AccuraSCOPE® Single Cell Full-Length Transcriptome Library Kit. AccuraSCOPE Single Cell Transcriptome and Genome Library Kit opens new possibilities for single cell multi-omic analysis by profiling […]
Collaboration aims to commercialise a Current Good Manufacturing Practice (cGMP) validated test to enable advanced and innovative analysis for multiple critical quality attributes of mRNA products The simplification of analytical testing requirements could accelerate the path to market for mRNA products such as vaccines for infectious diseases Lonza, a global development and manufacturing partner […]
Salvus, LLC seeks partner companies to commercialize technology that enables more timely PFAS management and remediation decisions VALDOSTA, Ga. — Salvus, LLC, a CJB Company, has entered into a licensing agreement with Georgia Tech Research Corporation (GTRC) to gain access to PFAS sensing technology for use in the Salvus™ Detection Platform, the world’s first handheld interferometric detector. Utilizing […]
WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY), today announced that Sophie Vandebroek and Michael Klobuchar have been elected to its board of directors, effective February 1, 2024. “I am pleased to welcome Michael Klobuchar and Sophie Vandebroek to Revvity’s board and look forward to their contributions as we execute on our strategic vision,” said Alexis Michas, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
